Data from Phase 3 trials of the coronavirus vaccine Covaxin, developed in India, has shown that two doses offer 77.8% protection against COVID-19, according...
The World Health Organization (WHO) recommends the widespread use of the first malaria vaccine Mosquirix (RTS, S / AS01), in children in sub-Saharan Africa...
The investigational oral antiviral drug molnupiravir is shown to reduce the risk of hospitalization and death in patients with mild or moderate covid-19 by...